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Mycoplasma genitalium is a sexually-transmitted bacterial pathogen that persists in 
patients by adherence to cells through matrix glycoproteins and evasion of host antibodies. 
The MgpB and MgpC adherence proteins consist of variable and conserved regions. 
Variable regions undergo antigenic variation to avoid specific antibodies. However, the C-
terminus (MgpB-4a) does not vary, is highly immunogenic, and antibodies to this region 
inhibit attachment and promote bacterial killing in vitro. To better understand how M. 
genitalium avoids clearance by antibodies to MgpB-4a in vivo we used surface plasmon 
resonance (SPR) to measure kinetic values of binding events. Binding of polyclonal rabbit 
antibodies (3935 and 3936) raised against MgpB-4a was measured against recombinant 
protein fragments truncated at the N- and C-termini. The two antibody sera produced by 
two separate, identical inoculations exhibit different kinetics and thermodynamics of 
binding while binding tightly and specifically to fragments of the mycoplasma adhesin 
domain MgpB-4a. Antibodies from both rabbits bound tightly to MgpB-4a fragments with 
dissociation constants of 10 nM-1 pM. A higher temperature (37°C) reduced binding of 
fragments to both antibodies, affecting 3936 more than 3935. Each antibody exhibits 
different kinetic signatures, with 3935 binding more tightly to smaller protein fragments 
and 3936 binding more tightly to larger fragments. Both antibodies bind tightly and with 
similar dissociation rates too slow to measure, differing most in on-rates. The 3935 and 
3936 antibodies are specific to the MgpB-4a domain, as other antibodies raised against 
MgpB-B bind to the same fragments at higher dissociation constants of 1 μM. Future 
experiments will compare these binding signatures to those of patient antibodies to explain 




Mycoplasma genitalium (Mg) is a sexually transmitted bacterial pathogen that 
causes a multitude of symptoms such as cervicitis in women and non-gonococcal 
urethritis in men (Wiesenfeld and Manhart). Mg infection can persist for months to years, 
and infection by Mg increases susceptibility to sexually transmitted infections such as 
HIV; Mg binding decreases the integrity of endocervical cells, increasing the passage of 
pathogens through epithelial barriers and causing infection (Vandepitte et al.) Mg 
infection affects between 1-3% of the US population and is primarily treated with 
Azithromycin and Doxycycline (Sliferski et al.; Bradshaw et al.). Alarmingly, multidrug 
resistance frequency is increasing, and previous treatment methods are becoming 
ineffective for patients leading to the necessity for the development of novel clinical 
treatments (Bradshaw et al.). These new therapies are aimed at replacing traditional 
antibiotics through identifying ways in which the bacteria persist in the body despite an 
immune response. 
Mg is able to evade the immune response by adherence to matrix glycoproteins, 
and through antigenic variation of epitopes. Epitopes are regions of an antigen molecule 
where an antibody binds, while matrix glycoproteins are extracellular macromolecules to 
which Mg binds, allowing it to persist in the body. The antibodies developed in a typical 
immune response to infection are raised primarily against the MgpB and MgpC adhesin 
proteins (McGowin and Totten). MgpB and MgpC are two proteins that allow Mg to 
adhere to endothelial cells. Using sub-tomogram averaging, previous research shows 
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these two proteins form a dimer complex consisting of 4 
lobes total in an extracellular domain* (Figure 1). These 
adhesin proteins are necessary for virulence, and 
sequencing of the MgpB and MgpC adhesin proteins reveal 
they consist of variable and conserved regions across 
bacterial samples. Specifically, a region within the C-
terminus of MgpB (recombinant protein MgpB-4a) does 
not vary and is highly immunogenic, located near the 
transmembrane domain of the protein (Figure 2). Antibodies to this region inhibit 
attachment and promote bacterial killing in vitro (McGowen and Totten).  Previous 
research on MgpB-4a has shown this region binds to fibronectin and plasminogen at 
different sites, suggesting this region consists of multiple binding sites for optimized cell 
adhesion (Mahlum et al.). 
 
To better understand how M. genitalium avoids clearance to MgpB-4a in vivo we 
used surface plasmon resonance (SPR) to measure kinetic and thermodynamic values of 
binding events to establish epitopes on the adhesin protein Mgp-4a. Knowledge of these 
binding sites can explain how antibodies are failing to bind sites that would result in 
clearance, and help us determine where they may be binding instead. Previous research 
Figure 1: Sub-tomogram 
average of MgpB/C adhesin 
complex. (Scheffer et al) 
Figure 2: Representational graph of MgpB protein showing the location of the 
recombinant protein MgpB-4a relative to entire sequence. (Iverson-Cabral et al.) 
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established SPR can be successfully used to measure binding affinities of antibodies to 
recombinant proteins (Mahlum et al.). SPR uses a light source aimed at a chip with bound 
protein, and this light is reflected off at a certain angle. When a protein is bound to a chip 
and an analyte in solution flows over, the analyte will then bind to the protein on the chip, 
and the total mass bound to the 
chip will increase. This results in 
a change in the refractive index 
(Figure 3). These changes in 
angles allow us to measure Kd, 
and on/off-rates of binding. A 
higher on-rate suggests little energy 
is required for binding, but a higher 
off-rate suggests the interaction 
formed is weak and dissociates quickly. The Kd relates these two values into a single 
constant, where Kd =
𝑘𝑜𝑛
𝑘𝑜𝑓𝑓
, so it is important to note equal Kd values can have differences 
in on and off rates, signifying different kinetics of binding despite a similar Kd.  Overall, 
a lower Kd suggests a smaller concentration of antibody is necessary to bind antigen and 
the antibody has high affinity for the antigen, with the opposite true for a higher Kd. 
Using either the recombinant proteins or polyclonal antibodies as analytes or ligands, we 
are able to measure the binding signatures of their interactions in real time. 
The purpose of this study is to evaluate the varying kinetic signatures of two 
polyclonal rabbit antibodies to explain how antibodies are avoided in vivo. Kinetic 
signatures involve on-rates, off-rates, and Kd binding constants: how quickly the 
Figure 3: Surface Plasmon Resonance (SPR) 
SPR measures changes in resonance angle in real time. This 
change is directly related to the amount of protein near the 




antibodies bind, how quickly they dissociate, and how much they bind overall. Using 
SPR, we are able to measure these different kinetic signatures and obtain 3 values for the 
binding events observed. Understanding the epitopes and kinetic signatures of these 
polyclonal antibodies will tell us how the immune system targets this bacterium and why 
it is failing to clear the infection. Future work focused on patient antibodies and how M. 
genitalium avoids clearance in vivo can help with the development of targeted therapies 






Materials and Methods 
Protein and Antibody Production and Purification (Aguila et. al.) 
MgpB-4a truncations and mutations were cloned into a pET plasmid vector. Proteins 
were expressed in BL21 alpha E. coli competent cells and were purified using nickel 
affinity chromatography. Using a BCA assay, purified protein concentrations were 
quantified. Rabbits were immunized with recombinant protein 4a (Figure 2). Serum was 
subsequently collected, and antibodies were purified using affinity-based purification 
kits.  
Surface Plasmon Resonance (SPR) Data Collection 
All reactions were completed at 25 oC unless otherwise stated. BIACORE X machine 
collected data in real time using BIACORE X Control Software. HBSEP buffer was used 
as solvent in all solutions unless otherwise stated. HBSEP was taken up by inlet tube 
during all CM5 chip data acquisition. FC1 was set as the blank, with no protein or 
antibody bound while FC2 was used as protein-bound channel.  
Determining Preconcentration 
The pH of solution can change the overall charge on a protein to allow for a positive 
protein to bind to the negatively charged surface of the chip. Different pH values can 
create a charged protein, and the best pH value was determined before each coupling to 
ensure chip would bind protein properly. Run settings set as: Multichannel, >10μL/min 
rate with reference cell=1. A blank CM5 chip was docked in the machine, with different 
pH conditions injected into the loop to determine optimum pH for coupling. Different pH 
conditions of sodium acetate buffer (pH=4.05, 4.51, 5.08, and 5.49) with a 1:10 dilution 
of protein to pH were injected. Regeneration in-between samples was done with 50 mM 
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NaOH. Best pH conditions were selected looking for highest response difference in flow 
channel 2. 
Collecting Preliminary Antibody/Protein Data 
Highest concentration in data acquisition of antibodies/protein with a coupled chip was 
determined through the use of serial dilutions ranging from 1:10-1:3000 with HBSEP. A 
response difference of ~100 was optimal for the high concentrations, as this difference 
suggests a detectable amount of analyte bound to chip without saturating binding sites. 
This is then used in a two-fold dilution series down to 1/32 of the high concentration. 
Regeneration of Surface Using NaOH 
Different concentrations of NaOH (ranging from 10-50 mM) was used to regenerate 
surface and interrupt protein-antibody binding. Regeneration allows for chip to remove 
any analyte not removed during wash procedure and frees up binding sites on the bound 
protein without unfolding the protein irreparably. 
Basic Data Acquisition 
Data acquisition was done using multichannel, 40μl/min with reference cell=1. Analyte 
injections during data acquisition done by injecting liquid followed by air-bubbles to 
avoid diluting the analyte with buffer. A blank of HBSEP, no delay, was injected into the 
loop. This was then repeated with a 180 second wash delay blank injection. Analytes 
were then injected from 1/32 dilution to high concentration with a 180 second wash 
delay. Regeneration was used as needed and repeats were completed if baselines drifted 
during data acquisition or bubbles interrupted analysis of binding events. 3 separate runs 




Surface Plasmon Resonance (SPR) Data Processing 
Data processing of antibody-protein binding curves was completed on BIAevaluation 
software. Equilibrium data and kinetic data were analyzed per individual run. For kinetic 
data, blank was subtracted from all analyte concentrations. Kinetics were fit with 
association and dissociation 1:1 Langmuir binding model. Kinetics were fit either 
simultaneously or separately (during antibody on chip experiments). Using triplicate data 
sets, average kon and koff values were determined, with most averages less than 20%. 
Errors (SE) were determined by incorporating magnitude of error with the measured 
values in accordance to previous research (McFarland). Dissociation time was 
determined by the wash delay (180 seconds). For samples that did not dissociate 
detectably within the set time period, a minimum rate constant of 10-5 s-1 was set. Beyond 




Results and Discussion 
The Mgpb-4a domain is 168 amino acids long and consists of multiple charged 
amino acids thought to be involved with antibody binding. Using their previous 
experience with microbiology and immunology, our collaborators identified these amino 
acids of interest and truncations/point mutations were designed that could aid in 
identifying binding sites. SUMO-tagged MgB-4a recombinant proteins with domain 
truncations at the N- and C-termini or introduction of point mutations at key arginine 
residues (Figure 4) were bound to polyclonal anti-MgpB-4a antibodies produced in two 
rabbits. Antibodies from both rabbits bound tightly to these recombinant proteins with 
Figure 4: MgpB-4a sequence, truncations, and mutations  
Recombinant proteins 3-5, with truncated N, C, or both termini, shown above with respective 
length and size relative to fragment 1 (full 4a domain sequence without transmembrane region). 
N and C terminals highlighted in MgpB-4a sequence above truncation representation. 2a-c point 
mutations, Arginine to Alanine point mutations, are underlined/bolded in the sequence above. 








dissociation constants in the nanomolar to picomolar range (Figure 5). Antibodies from 
rabbits immunized with a different domain of the MgpB adhesin protein (MgpB-B) 
bound MgpB-4a fragments with weak binding constants in the micromolar range or 
weaker, suggesting the two rabbit antibodies explored here exhibit specific binding to 
these SUMO MgB-4a constructs. SUMO tags were used for purification as previous data 










Figure 5: 3936 and 3935 antibodies bind tightly to antigen, but with 
different kinetic signatures 
Kon/Koff plot for the 3936 and 3935 kinetic signatures measured via SPR and evaluated on 
BIAeval. Orange arrow shows differences of binding patterns at 37C for fragment 3. Blue 
arrows show differences in binding of 3936 between truncations, binding more tightly to larger 
recombinant proteins.  3936 binds most tightly to fragment 1 at close to 1pM. Yellow arrows 
shows difference in binding of 3935 between truncations, binding more tightly to the smaller 




The polyclonal rabbit antibodies responded differently to the truncated 
recombinant protein, the 2a, 2b, and 2c Arg-to-Ala mutation, and increased temperature 
(Figure 5). For both antibodies, a higher temperature reduced on-rates and off-rates were 
unaffected within detection limits.  
For 3936, temperature and truncation decreased on-rates meaning there are 
multiple sites on the protein to which the polyclonal antibodies bind and truncating either 
end of the protein reduces the total binding sites available. Overall, this suggests 3936 
possesses distributed epitopes across the C-terminal domain of MgpB. 3936 bound 
tightest to fragment 1, or the full 4a domain, with a Kd close to 1pM (Figure 4). Mutation 
R80A also decreased on-rates for 3936, destabilizing binding as might be expected for 
long-range electrostatic attraction.  
Alternatively for 3935, smaller domains bound with increased on-rates which may 
indicate binding concentrated to the central region of the C-terminal domain. This region 
was conserved in all truncations, unlike flanking regions. 3935 preferentially bound to the 
C-terminal half of 4a-2a (fragment 3) with a Kd close to 5pM (Figure 5). Mutation R80A 
(R1236A relative to entire MgpB protein) decreased off-rates for 3935, stabilizing the 
interaction. We hypothesize that this arginine’s positive charge (located in the center, 
near the N-terminal half of the domain) destabilizes the bound antibody-antigen complex 
due to positive charges in the antigen’s epitope.   
All experiments exploring effects of truncation and temperature on kinetic 
signatures of polyclonal antibodies were completed with the antigen bound to the chip. A 
set of experiments coupling the antibody to the chip with the antigen as analyte showed a 
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difference in binding signatures. We expected to see enhanced binding due to the avidity 
effect when the antigen is coupled to the chip relative to when the antibody is coupled. 
 
 
Once the antibody was coupled to the chip (creating a “flipped chip”) and a 
recombinant protein was used as an analyte, on-rates increased slightly, and off-rates 
increased significantly compared to previous rates with the antigen coupled to the chip. 
For all 3 flipped chips, Kd decreased by ~1-2 orders of magnitude with an antibody chip, 
consistent with increased avidity (Figure 6). When an antigen is attached to a surface, we 
expect the avidity effect to enhance binding of the antibody analyte flowing over the 
Figure 6: Attaching the antibody rather than the antigen to the chip results in binding 
changes that are consistent with the avidity effect 
Kon/Koff plot for the 3936 and 4673 (anti-MgpB-B) kinetic signatures measured via SPR and evaluated on BIAeval. 





surface as it is bivalent, resulting in a lower Kd relative to when the antibody is instead 
coupled to the chip. 
 
Overall, both antibodies bind tightly, but with distinct kinetic signatures and 
distinct specificities to truncated domains despite similar experimental origins (Figure 7). 
The 3936 antibody sample binds more peptides, consistent with a broader interaction in 
which epitopes are distributed throughout the 4a domain. The 3935 antibody sample 
preferentially binds truncated peptides containing C-terminal regions rather than N-
terminal regions, indicating epitopes in the C-terminal half of the domain. 
 
 
Figure 7: MgpB-4a antibody Kd affinity 
Recombinant proteins 4a-3,4, and 5, with truncated N, C, or both termini shown above with length 
and size relative to fragment 4a-1.  Fragment 4a-1 refers to full sequence + transmembrane region. 
His tags on beginning and end of fragments. 3935, on bottom, is more specific and binds best to C-
terminal recombinant protein. 3936, on top, is less specific and binds best to longer proteins. 4a-
2a has a point mutation from Arg-Ala at R80A (R1263A), not shown above. Smaller Kd values in 
green, increasing Kd  in yellow, and largest Kd in orange. Decreasing Kd is indicative of tighter 




 Mapping the kinetic signatures of these rabbit polyclonal antibodies establishes 
groundwork for understanding how Mycoplasma genitalium avoids the immune response 
in vivo. Our findings suggest the two polyclonal antibody sera have differing targets on 
the adhesin protein and range in their distribution of epitopes. Comparing binding 
signatures to disease severity and longevity can help map what antibody epitopes and 
distributions are effective in clearing infection and which are not. Future work involving 
mapping human antibody epitopes to MgpB-4a or other immunogenic regions of the 
MgpB adhesin protein can aid in the process of assisting the natural immune response 
and creating effective strategies that can target the bacteria in vivo. We also hope to 
repeat this research similarly using primate and human sera or other recombinant proteins 
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Appendix on Faith and Science  
 As a Christian scholar, the intersection between my faith and passion for science 
is dynamic and closely intertwined. As Francis Collins gracefully explains, “the God of 
the Bible is also the God of the genome. He can be worshipped in the cathedral or in the 
laboratory” (Collins 78). My own worship takes place intellectually; as a person focused 
on the accumulation of knowledge and reasoning, my appreciation for God’s creation is 
found within the natural laws that He has given to us to explore. This understanding of 
my own personal strengths and my strong background within the Nazarene church have 
helped me view a Christian scholar as one who views God as the truth behind all things, 
even science. 
 Growing up in a Nazarene church in Olathe, Kansas provided me with many 
wonderful benefits to understanding Christianity, but also introduced obstacles for 
engaging in outside cultures. The Nazarene church places heavy emphasis on the value of 
“reason, experience, sanctification, and freedom” (Hughes 346). While the community is 
an important aspect of these tenants of holiness, individual journeys are stressed, and 
each walk of faith is seen as a personal experience. To understand fully the culture within 
the Nazarene church, recognition of its past is important. After WWI, an increase in a 
counter-culture movement spread throughout all Nazarene churches as isolation from the 
temptation of the world was equivalent to moral integrity. Legalism, intolerance, and 
quarantine were promoted throughout the church across the nation. A “Christ against 
culture” community was fostered, prompting many to attempt to protect themselves from 
the temptations of people not like them (Hughes 351).  College Church of the Nazarene 
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in Olathe has echoes of these legalistic sentiments still found in the congregation, 
specifically among older generations who were raised within its boundaries. While the 
church is full of loving, God-fearing people, these intense rules of self-restraint can feel 
restrictive to many and the church has recently been declining in numbers. Modernization 
is re-shaping the church in many ways, but a balance of understanding and growing with 
the world without the danger of secularism is still being molded. 
New movements of “sanctification as a journey” and the revitalization of the 
community are spreading within the Nazarene church, aligning to the time I was growing 
up in CCN (Hughes 347). I still have recognized many of the legalistic tendencies that 
prevail within my own background and are continuously growing and shaping this area of 
my life. As “Christian faith constantly becomes enmeshes with cultural forces”, my own 
church’s culture shaped my faith into many great things and many things that do not 
reflect the glory of God (Marsden 100). As a science-driven person, the strict adherence 
to rules was an easier way for me to live a life of faith and I was comfortable living inside 
the Nazarene church “bubble”. However, moving to Seattle has shown me that a faithful 
life also takes passion and deep love for others, not just an understanding of how to live 
with self-restraint. Jesus was full of intensity for loving all people and a life without sin – 
not the following of a set of rules. I appreciate the value my church has given me in 
following the bible, but I have had to develop ways to interact with the world outside the 
church on my own and learn that this adventuring out of the church’s walls is inherent to 
a strong Christian faith. 
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 The Nazarene church still continues to hold reason in high regard, specifically 
promoting the ideas of a higher education after high school. As shown, this can result in 
authoritarian-like regulations, but also results in the fostering of intellect within the 
community. Science, in general, is not feared by the Nazarene church but misunderstood; 
as many in older generations have told me, they do not “believe” in evolution simply 
because they do not understand it fully but do not think it is anti-Christian. Because of 
this appraisal of science within my community, my enjoyment of investigation and 
exploration in my science classes was always met with positivity. As a woman, many 
encouraged me even further to enter the STEM fields as they believed it would be great 
for gender equality; the Nazarene church, while still needing more gender reform, was 
one of the first denominations to promote the ideas of women pastors. At one point in 
high school, I attended a sermon interviewing leading scientists on new interpretations of 
the creation story in tandem with evolution alongside those with a young earth 
creationism background. This promoted my individual desire to be a scientist, while also 
showing to me that the church and science belong in conversation and debate together; 
one does not negate the necessity for the other. I think I owe much of my appreciation for 
science to CCN and am forever grateful for the fostering of intellectual growth that took 
place there.  
Growing up as a quiet, intellectually-driven girl I have always tried to understand 
how the gifts of scientific investigation could be used to help others, as a part of me 
thought I could never do anything for the glory of God like the missionaries did. While 
my church never disregarded my scientific desires, I always felt slightly guilty about my 
desire to work in science rather than going out to preach the word of God. After learning 
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more about my strengths throughout high school and realizing that God can use them to 
help others medically, I have always felt confident in my decision to pursue a higher 
education and research in the war against cancer. As Paul Farmer puts it, “I feel most 
alive… when I'm helping people” (Kidder 57). Paul Farmer is a perfect example of using 
the strengths God has given to bring light back into the world. While I may never be a 
doctor who travels around the world helping others or a missionary gifted with eloquent 
speech, I can do my own part to make God’s will a reality. None of these testaments to 
God’s will are more holy than the other; I have learned my work is just as important.  
Within cancer research, I’ve always had a strong personal connection to my work 
outside of my love for scientific exploration. After losing my mother to lung cancer at the 
age of 13, I have always desired to rid the world of the disease completely. I have always 
strongly argued against the ideas of “everything happens because God wills it to be”, 
instead choosing to believe that God uses us within the circumstances of the fallen world 
to bring light back. God can work despite the suffering of the world, but he does not will 
it so. Because of this, I have always believed my calling was to work within cancer 
research because God was able to spark a fire for my passion despite a terrible tragedy. 
My honors project participates in the understanding of a disease linked to an increase in 
susceptibility to cancer, reflecting my long-term desires to work in this field to do my 
own part of healing this broken world. 
As a person of faith, I am able to use the gifts God has given me to improve the 
world around me. These gifts, to many, seem antithetical to faith but are actually complex 
and intertwined. My journey growing up within the Nazarene church and suffering 
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through grief has provided me with the opportunity to be a Christian scholar within 
cancer research. My academic work is a way in which I can worship God as He is the 
truth behind all things, including scientific investigations. A relationship with God, to me, 
involves an analysis of how one works best to bring God’s glory into the world and 
allowing this understanding of self to be a way in which God can be truly worshiped.  
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